Inspire Medical Systems I... (INSP)
Inspire Medical Systems Inc. (INSP) Stock Price, Analysis & Data
Keine Daten verfügbar
| Geld | n/a |
| Marktkapitalisierung | 1.66 Mrd |
| Umsatz (TTM) | 898.74 Mio |
| Nettogewinn (TTM) | 135.04 Mio |
| Beta | 0.67 |
| EPS (ttm) | 4.54 |
| KGV (TTM) | 12.64 |
| Forward-KGV | 37.33 |
| KBV (TTM) | 2.01 |
| KUV (TTM) | 1.85 |
| Earnings Date | Nov 2, 2026 |
| Brief | n/a |
| Volumen | 315,209 |
| Ø Vol. (20D) | 973,226 |
| Eröffnung | 57.32 |
| Vortagesschluss | 57.22 |
| Tagesspanne | 57.00 - 57.98 |
| 52-Wk Range | 38.91 - 147.03 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über INSP
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously m...
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Inspire Medical Systems 911.98 Mio, ein Anstieg von 13.6% im Vergleich zum Vorjahr (802.8 Mio). Der Gewinn lag bei 145.42 Mio, ein Anstieg von 171.77 %.
FinanzberichteGewinnüberraschung
Analysten erwarten einen Umsatz von ... Upgrade
vor 3 Tagen · Simply Wall St.
Inspire Medical Systems (INSP) Stock May Be Cheap After A 74% FallInspire Medical Systems stock has had a difficult run over the past three years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares tra...
